CANCER GENETICS, INC
CANCER GENETICS, INC (CGIX) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 114 transactions totaling $6.2M, demonstrating a bullish sentiment with $2.8M in net insider flow. The most recent transaction on Jan 31, 2019 involved a purchase of 1,000,000 shares valued at $230.0K.
CGIX Insider Activity Summary
Who Is Buying CGIX Stock?
No significant insider buying has been recorded for CGIX in the recent period.
Who Is Selling CGIX Stock?
No significant insider selling has been recorded for CGIX in the recent period.
Is CANCER GENETICS, INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CGIX is bullish with an Insider Alignment Score of 72/100 and a net flow of $2.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
CGIX Frequently Asked Questions
Understanding CGIX Insider Activity
Insider trading at CANCER GENETICS, INC (CGIX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading CGIX stock, having executed 114 transactions in the past 90 days. The most active insider is John Pappajohn (Executive), who has made 47 transactions totaling $4.4M.
Related Tools
Track CANCER GENETICS, INC Insider Activity
Get notified when executives and directors at CGIX file new Form 4 transactions